Full Paper
1H NMR (400 MHz, 258C, CDCl3): d=À2.81 (bs, 2H, NH), 1.59 (s,
1H NMR (400 MHz, 258C, DMSO): d=À2.92 (bs, 2H, NH), 1.99 (t,
3J=8.0 Hz, 24H, CH2CH2CO), 2.25 (t, 3J=8.0 Hz, 24H, CH2CH2CO),
3
36H, CH3), 4.80 (s, 8H, CH2), 7.26 (d, J=8.5 Hz, 8H, CH-benz), 8.10
(d, 3J=8.5 Hz, 8H, CH-benz), 8.83 ppm (s, 8H, CH-pyrr); 13C NMR
(400 MHz, 258C, CDCl3): d=14.48 (s, 12C, CH3), 52.38 (s, 4C, CH2),
68.91 (s, 4C, CCH3), 99.22 (s, 8C, CH-benz), 105.85 (s, 4C, C-por),
121.75 (s, 4C, C-C-benz), 121.83 (s, 8C, CH-benz), 144.14 (s, 4C, C-O-
benz), 154.48 ppm (s, 4C, COOCCH3); MS (MALDI, sin): m/z: 1135
[M]+, 1136 [M+H]+, 1137 [M+2H]+; HRMS (ESI-TOF, MeOH-ACN):
m/z calcd for C68H70N4O12: 1135.5063 [M]+; found: 1135.5049 [M]+.
4.77 (s, 8H, CH2), 7.38 (d, J=8.4 Hz, 8H, CH-benz), 7.58 (s, 4H, 6),
3
3
8.12 (d, J=8.4 Hz, 8H, CH-benz), 8.87 (s, 8H, CH-pyrr), 12.15 ppm
(bs, 12H, COOH); 13C NMR (400 MHz, 258C, DMSO): d=28.10 (s,
12C, CH2CH2CO), 29.24 (s, 12C, CH2CH2CO), 56.96 (s, 4C, CONHC),
67.03 (s, 4C, CH2), 113.14 (s, 8C, CH-benz), 119.57 (s, 7C, C-por),
131.47 (m, 8C, CH-pyrr), 133.99 (s, 4C, C-C-benz), 135.33 (s, 8C, CH-
benz), 157.79 (s, 4C, C-O-benz), 167.23 (s, 4C, CONH), 174.47 ppm
(s, 12C, COOH); HRMS (ESI-TOF, ACN-MeOH-HCOOH): m/z calcd for
5,10,15,20-(Phenoxyacetic acid)-porphyrin (6): 5,10,15,20-(tert-
Butyl-2-phenoxyacetato)-porphyrin (334 mg; 0.29 mmol) was dis-
solved in formic acid (25 mL). The solution was stirred for 18 h at
room temperature. The formic acid was removed on a rotary evap-
orator. Subsequently, the product was transferred to toluene and
evaporated twice to remove any residual formic acid. The product
was finally dried under reduced pressure. Yield: 260 mg
(0.28 mmol), 99%.
C92H98N8O32: 936.3036 [M+2Na]2+
,
1826.6282 [M]+, 1827.6360
[M+H]+, 1849.6179 [M+Na]+; found: 936.3019 [M+2Na]2+
1827.6279 [M]+, 1827.6279 [M+H]+, 1849.6154 [M+Na]+.
,
Functionalization of TiO2 nanoparticles with N1,N7-bis(3-(4-
tert-butylpyridium-methyl)phenyl)-4-(3-(3-(4-tert-butylpyridi-
nium-methyl)phenylamino)-3-oxopropyl)-4-(3,4-dihydroxy-
benzamido)heptanediamide tribromide (1)
1H NMR (400 MHz, 258C, DMSO): d=À2.91 (s, 2H, NH), 4.97 (s, 8H,
3
3
An ethanolic suspension (16.67 mgmLÀ1) of P-25 TiO2 nanoparticles
(purchased from Evonic) was prepared. For investigation of the
functionalization of the TiO2 surface, a suspension of TiO2 nanopar-
ticles (washed once with EtOH) was mixed with different quantities
of 1 in ethanol [16.272ꢂ10À7 (T1), 4.068ꢂ10À7 (T2), 2.034ꢂ10À7
(T3), 1.017ꢂ10À7 (T4), 0.508ꢂ10À7 (T5), 0.254ꢂ10À7 (T6), and
0 molmgÀ1 (T7)]. The overall TiO2 concentration for the functionali-
zation was adjusted to 2.08 mgmLÀ1. The mixture was sonicated
for 50 min at room temperature. Subsequently, the suspensions of
TiO2 nanoparticles were centrifuged until the TiO2 nanoparticles
settled completely. The supernatant was removed and the particles
were washed three times by the addition of 5 mL ethanol followed
by sonication until redispersion was completed, followed by centri-
fugation until the TiO2 nanoparticles settled completely. After the
last washing step, the TiO2 nanoparticles were dispersed in ethanol
CH2), 7.35 (d, J=8.4 Hz, 8H, CH-benz), 8.12 (d, J=8.4 Hz, 8H, CH-
benz), 8.84 (s, 8H, CH-pyrr), 13.16 ppm (bs, 4H, COOH); 13C NMR
(400 MHz, 258C, DMSO): d=64.84 (s, 4C, CH2), 113.04 (s, 8C, CH-
benz), 119.57 (s, 4C, C-por), 133.94 (s, 4C, C-C-benz), 135.31 (s, 8C,
CH-benz), 157.73 (s, 4C, C-O-benz), 170.32 ppm (s, 4C, COOH); MS
(MALDI, om): m/z: 911 [M]+, 912 [M+H]+, 913 [M+2H]+; HRMS
(ESI-TOF, MeOH-THF): m/z calcd for C52H38N4O12: 910.248074 [M]+;
found: 910.244958 [M]+; calcd for C52H39N4O12: 911.255899 [M+H]+;
found: 911.252284 [M+H]+.
5,10,15,20-(Di-tert-butyl-4-(3-(tert-butoxy)-3-oxopropyl)-4-(2-phe-
noxyacetamido)heptanedionato)-porphyrin (7): 5,10,15,20-(Phe-
noxyacetic acid)-porphyrin (140 mg; 0.15 mmol) was dissolved in
DMF (25 mL) and the solution was cooled to 08C. Di-tert-butyl-4-
amino-4-(3-(tert-butoxy)-3-oxopropyl)heptanedionate (461.32 mg;
1.11 mmol) was added, then DCC (216.37 mg; 1.05 mmol) and
HOBT (141.88 mg; 1.05 mmol) were added and the solution was
stirred for three days at room temperature. The solvent was re-
moved under reduced pressure on a rotary evaporator and the
product was purified through column chromatography over silica
with a mixture of CH2Cl2 and EtOAc (4:1) as eluent. Yield: 273 mg
(0.11 mmol), 79%.
to obtain a particles suspension of 4.81 mgmLÀ1
.
Preparation of tris(hydroxymethyl) aminomethane buffer
solutions
A 0.1m aqueous solution of tris(hydroxymethyl) aminomethane
was prepared and subsequently adjusted to pH 9 with 0.1m HCl
solution.
1H NMR (400 MHz, 258C, CDCl3): d=À2.79 (s, 2H, NH), 1.44 (s,
3
3
108H, CH3), 2.14 (t, J=8.6 Hz, 24H, CH2CH2CO), 2.34 (t, J=8.6 Hz,
3
24H, CH2CH2CO), 4.69 (s, 8H, CH2), 6.84 (s, 4H, CONH), 7.34 (d, J=
8.6 Hz, 8H, CH-benz), 8.16 (d, J=8.6 Hz, 8H, CH-benz), 8.84 ppm (s,
3
Preparation of poly-(diallyl-dimethylammonium) (PDDA) and
poly-(sodium-4-styrene-sulfonato) (PSS) solutions
8H, CH-pyrr); 13C NMR (400 MHz, 258C, CDCl3): d=28.00 (s, 36C,
CH3), 29.66 (s, 12C, CH2CH2CO), 29.97 (s, 12C, CH2CH2CO), 57.68 (s,
4C, CONHC), 67.54 (s, 4C, CH2), 80.62 (s, 12C, CCH3), 112.96 (s, 8C,
CH-benz), 119.30 (s, 4C, C-pyr), 135.58 (s, 8C, C-C-benz), 135.88 (s,
4C, CH-benz), 156.88 (s, 4C, C-O-benz), 167.25 (s, 4C, CONH),
172.48 ppm (s, 12C, COOCCH3); MS (MALDI, dctb): m/z: 2501 [M]+,
2502 [M+H]+; HRMS (ESI-TOF, ACN-MeOH): m/z calcd for
0.5% PDDA and PSS solutions at pH 3 and pH 4, respectively, were
prepared from a 20 wt% solutions in water (Mw =400000–500000;
PDDA) and an 18 wt% solution in water (Mw =1000000; PSS), pur-
chased from Aldrich.
C140H194N8Na2O32: 1272.6792 [M+2Na]2+
[M+2Na]2+, 856.4538 [M+3Na]3+
;
found: 1272.6822
Formation of layer-by-layer assemblies
.
For the buildup of layer-by-layer assemblies on different substrates,
the following sequences were used: 1) dipping of the substrate
into a solution of 0.5% PDDA+ at pH 3 for 10 min; 2) rinsing with
ethanol/water 1:1 (v/v); 3) dipping into a solution of 0.5% PSSÀ at
pH 4 for 10 min; 4) rinsing with ethanol/water 1:1 (v/v); 5) dipping
into a 10À3 m ethanolic suspension of TiO2 nanoparticles for
10 min; 6) rinsing with ethanol; 7) dipping into a 10À3 m TRIS buffer
solution at pH 9 of 2 or 3, respectively, for 10 min; 8) rinsing with
ethanol/water 1:1 (v/v). Sequences 1–4) were repeated up to four
times. Depending on whether the first deposited layer should con-
5,10,15,20-(4-(2-Ethoxycarbonyl)-4-(2-phenoxyacetamido)hepta-
nedioic acid)-porphyrin (8): 5,10,15,20-(Di-tert-butyl-4-(3-(tert-
butoxy)-3-oxopropyl)-4-(2-phenoxy-acetamido)heptanedionato)-
porphyrin (140 mg; 0.056 mmol) was dissolved in formic adic
(40 mL) and stirred for 4 h at room temperature. The formic acid
was removed on a rotary evaporator. Subsequently, the product
was transferred to toluene and evaporated twice to remove any re-
sidual formic acid. The product was finally dried under reduced
pressure. Yield: (0.056 mmol), 100%.
&
&
Chem. Eur. J. 2015, 21, 1 – 15
12
ꢁ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!